Kerr Financial Planning’s BioNTech BNTX Stock Holding History

Kerr Financial Planning’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100	Closed	-$10.3K	–	516
2025 Q3	$10.3K	Buy	+100	New	+$10.7K	0.01%	352

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kerr Financial Planning's BNTX Position: Q4 2025 in Review

Kerr Financial Planning sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 100 shares — an estimated $10.3K sold.

Kerr Financial Planning first reported a position in BNTX in Q3 2025 and held it in 1 quarter. The position peaked at $10.3K in Q3 2025. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

Kerr Financial Planning reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
Kerr Financial Planning sold 100 BioNTech shares in Q4 2025, an estimated $10.3K.
Kerr Financial Planning first reported a position in BioNTech in Q3 2025 and held it in 1 quarter.
Kerr Financial Planning's BioNTech position peaked at $10.3K in Q3 2025.
284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Kerr Financial Planning's 13F filing for Q4 2025, filed 10 Feb 2026.